David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Criteo S.A.
CRTO
$848M
| $13.1M | 0.01% |
579,911
+169,864
| +41% | +$3.98M |
|
1377
CALL
SLB Ltd
SLB
$79.1B
| $13.1M | 0.01% |
381,200
-147,800
| -28% | -$5.14M |
|
1378
Charter Communications
CHTR
$18.5B
| $13.1M | 0.01% |
47,482
-87,784
| -65% | -$26.5M |
|
|
ALF
1379
Centurion Acquisition Corp
ALF
| $13.1M | 0.01% |
1,237,500
| – | – |
|
|
VLOS
1380
Velos Acquisition I Corp
VLOS
$252M
| $13.1M | 0.01% |
1,237,500
| – | – |
|
1381
PUT
W.W. Grainger
GWW
$61.3B
| $13.1M | 0.01% |
13,700
-17,300
| -56% | -$17.4M |
|
1382
Expedia Group
EXPE
$40.6B
| $13M | 0.01% |
61,025
-67,170
| -52% | -$13.5M |
|
1383
Genuine Parts
GPC
$19B
| $13M | 0.01% |
94,084
+70,667
| +302% | +$9.48M |
|
|
LX
1384
LexinFintech Holdings
LX
$214M
| $13M | 0.01% |
2,442,093
+1,945,872
| +392% | +$12.4M |
|
1385
BioCryst Pharmaceuticals
BCRX
$2.51B
| $13M | 0.01% |
1,709,336
-2,680,141
| -61% | -$22.3M |
|
1386
News Corp Class B
NWS
$19B
| $13M | 0.01% |
375,163
+231,592
| +161% | +$7.82M |
|
1387
Sensient Technologies
SXT
$5.82B
| $12.9M | 0.01% |
137,821
+88,347
| +179% | +$9.67M |
|
1388
Dorman Products
DORM
$3.87B
| $12.9M | 0.01% |
82,793
-16,295
| -16% | -$2.34M |
|
1389
Dole
DOLE
$1.28B
| $12.9M | 0.01% |
960,172
+944,584
| +6,060% | +$13.2M |
|
|
CCIX
1390
DELISTED
Churchill Capital Corp IX
CCIX
| $12.9M | 0.01% |
1,230,669
| – | – |
|
1391
CALL
Blackstone
BX
$108B
| $12.9M | 0.01% |
75,400
-57,900
| -43% | -$9.92M |
|
1392
PUT
Chewy
CHWY
$10.1B
| $12.9M | 0.01% |
318,300
+83,500
| +36% | +$3.22M |
|
|
BEAG
1393
Bold Eagle Acquisition Corp
BEAG
$337M
| $12.9M | 0.01% |
1,237,500
| – | – |
|
1394
Telus
TU
$15.5B
| $12.9M | 0.01% |
816,678
-780,900
| -49% | -$12.7M |
|
|
MRLN
1395
Merlin Inc
MRLN
$339M
| $12.9M | 0.01% |
1,237,500
| – | – |
|
1396
Prothena Corp
PRTA
$484M
| $12.8M | 0.01% |
1,315,418
+923,923
| +236% | +$7.1M |
|
1397
Fulgent Genetics
FLGT
$549M
| $12.8M | 0.01% |
567,770
+91,282
| +19% | +$1.88M |
|
1398
PUT
Pembina Pipeline
PBA
$28B
| $12.8M | 0.01% |
316,400
| – | – |
|
1399
Ramaco Resources Class A
METC
$819M
| $12.8M | 0.01% |
+384,264
| New | +$8.93M |
|
1400
Target
TGT
$74.2B
| $12.7M | 0.01% |
141,863
+109,819
| +343% | +$10.8M |
|
Similar funds
David Shaw's Q3 2025 Portfolio in Review
As of Q3 2025, David Shaw held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- David Shaw's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- David Shaw added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- David Shaw's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- David Shaw fully exited Hess in Q3 2025, selling an estimated $527M.
- David Shaw's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- David Shaw opened 714 new positions and closed 514 in Q3 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.